Moderna’s stock boosted by positive data from trial of melanoma treatment combined with Merck’s Keytruda
December 14, 2023 at 10:29 AM EST
Moderna's stock was on track for its biggest one-day gain in more than a year.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
